PlainRecalls
FDA Drug Critical Class I Terminated

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27

Reported: September 27, 2017 Initiated: September 5, 2017 #D-1175-2017

Product Description

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27

Reason for Recall

Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.

Details

Recalling Firm
Genentech, Inc.
Units Affected
16,882
Distribution
Nationwide in the USA
Location
South San Francisco, CA

Frequently Asked Questions

What product was recalled?
Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27. Recalled by Genentech, Inc.. Units affected: 16,882.
Why was this product recalled?
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 27, 2017. Severity: Critical. Recall number: D-1175-2017.